| 1 |
34896750 | BTK-inhibitor drug covalent binding to lysine in human serum albumin using LC-MS/MS. | 2022 Feb |
1 |
| 2 |
35247543 | Novel Bruton's tyrosine kinase inhibitor remibrutinib: Assessment of drug-drug interaction potential as a perpetrator of cytochrome P450 enzymes and drug transporters and the impact of covalent binding on possible drug interactions. | 2022 May 1 |
1 |
| 3 |
35587148 | Improved Electrophile Design for Exquisite Covalent Molecule Selectivity. | 2022 Jun 17 |
2 |
| 4 |
32979005 | Chemoproteomic Profiling of an Ibrutinib Analogue Reveals its Unexpected Role in DNA Damage Repair. | 2021 Jan 5 |
1 |
| 5 |
33761747 | Tunable Methacrylamides for Covalent Ligand Directed Release Chemistry. | 2021 Apr 7 |
1 |
| 6 |
30442651 | Bioavailability, Biotransformation, and Excretion of the Covalent Bruton Tyrosine Kinase Inhibitor Acalabrutinib in Rats, Dogs, and Humans. | 2019 Feb |
1 |
| 7 |
27641927 | Ibrutinib inhibition of Bruton protein-tyrosine kinase (BTK) in the treatment of B cell neoplasms. | 2016 Nov |
2 |